XML 25 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Investment Securities
3 Months Ended
Mar. 31, 2022
Investment Securities [Abstract]  
Investment Securities
(4) Investment Securities

(a) Securities available for sale

The amortized cost and fair value of the securities available for sale are as follows:

 
March 31, 2022
 
(dollars in thousands)
 
Amortized
Cost
   
Gross
Unrealized
Gains
   
Gross
Unrealized
Losses
   
Fair
Value
 
                         
U.S. government sponsored enterprises
 
$
64,978
     
-
     
2,919
     
62,059
 
State and political subdivisions
   
41
     
-
     
-
     
41
 
Mortgage backed securities and collateralized mortgage obligations - residential
   
257,248
     
80
     
13,283
     
244,045
 
Corporate bonds
   
76,086
     
49
     
2,046
     
74,089
 
Small Business Administration - guaranteed participation securities
   
29,181
     
-
     
1,095
     
28,086
 
Other
   
686
     
-
     
15
     
671
 
Total Securities Available for Sale
 
$
428,220
     
129
     
19,358
     
408,991
 

 
December 31, 2021
 
(dollars in thousands)
 
Amortized
Cost
   
Gross
Unrealized
Gains
   
Gross
Unrealized
Losses
   
Fair
Value
 
                         
U.S. government sponsored enterprises
 
$
59,976
     
-
     
797
     
59,179
 
State and political subdivisions
   
41
     
-
     
-
     
41
 
Mortgage backed securities and collateralized mortgage obligations - residential
   
269,907
     
3,367
     
2,476
     
270,798
 
Corporate bonds
   
45,805
     
157
     
625
     
45,337
 
Small Business Administration - guaranteed participation securities
   
31,303
     
371
     
-
     
31,674
 
Other
   
685
     
-
     
1
     
684
 
Total securities available for sale
 
$
407,717
     
3,895
     
3,899
     
407,713
 

The following table distributes the debt securities included in the available for sale portfolio as of March 31, 2022, based on the securities’ final maturity. Actual maturities may differ because of securities prepayments and the right of certain issuers to call or prepay their obligations without penalty. Securities not due at a single maturity date are presented separately:

(dollars in thousands)
 
Amortized
Cost
   
Fair
Value
 
             
Due in one year or less
 
$
10,071
     
10,120
 
Due in one year through five years
   
131,720
     
126,740
 
Due after five years through ten years
   
-
     
-
 
Mortgage backed securities and collateralized mortgage obligations - residential
   
257,248
     
244,045
 
Small Business Administration - guaranteed participation securities
   
29,181
     
28,086
 
   
$
428,220
     
408,991
 


Gross unrealized losses on securities available for sale and the related fair values aggregated by the length of time that individual securities have been in an unrealized loss position, were as follows:

 
March 31, 2022
 
   
Less than
12 months
   
12 months
or more
   
Total
 
(dollars in thousands)
 
Fair
Value
   
Gross
Unrealized
Loss
   
Fair
Value
   
Gross
Unrealized
Loss
   
Fair
Value
   
Gross
Unreal.
Loss
 
                                     
U.S. government sponsored enterprises
 
$
23,723
     
1,264
     
38,336
     
1,655
     
62,059
     
2,919
 
Mortgage backed securities and collateralized mortgage obligations - residential
   
160,318
     
5,999
     
73,797
     
7,284
     
234,115
     
13,283
 
Corporate bonds
   
49,993
     
1,115
     
14,070
     
931
     
64,063
     
2,046
 
Small Business Administration - guaranteed
participation securities
    28,086       1,095       -       -       28,086       1,095  
Other
    585       15       -       -       585       15  
                                                 
Total
 
$
262,705
     
9,488
     
126,203
     
9,870
     
388,908
     
19,358
 

 
December 31, 2021
 
   
Less than
12 months
   
12 months
or more
   
Total
 
(dollars in thousands)
 
Fair
Value
   
Gross
Unrealized
Loss
   
Fair
Value
   
Gross
Unrealized
Loss
   
Fair
Value
   
Gross
Unreal.
Loss
 
                                     
U.S. government sponsored enterprises
 
$
49,279
     
697
     
9,900
     
100
     
59,179
     
797
 
Mortgage backed securities and collateralized mortgage obligations - residential
   
93,447
     
1,888
     
22,098
     
588
     
115,545
     
2,476
 
Corporate bonds
   
15,670
     
171
     
14,546
     
454
     
30,216
     
625
 
Other
    648        1
      -
       -
      648
      1
 
                                                 
Total
 
$
159,044
     
2,757
     
46,544
     
1,142
     
205,588
     
3,899
 

There were no allowance for credit losses recorded for securities available for sale during the three months ended March 31, 2022.

The proceeds from sales and calls and maturities of securities available for sale, gross realized gains and gross realized losses from sales and calls during the three months ended March 31, 2022 and 2021 are as follows:

 
Three months ended March 31,
 
(dollars in thousands)
 
2022
   
2021
 
             
Proceeds from sales
 
$
-
   

-
 
Proceeds from calls/paydowns
   
17,923
     
36,820
 
Proceeds from maturities
   
5,000
     
55
 
Gross realized gains
   
-
     
-
 
Gross realized losses
   
-
     
-
 

(b) Held to maturity securities

The amortized cost and fair value of the held to maturity securities are as follows:

 
March 31, 2022
 
(dollars in thousands)
 
Amortized
Cost
   
Gross
Unrecognized
Gains
   
Gross
Unrecognized
Losses
   
Fair
Value
 
                         
Mortgage backed securities and collateralized mortgage obligations - residential
 
$
9,183
     
383
     
16
     
9,550
 
                                 
Total held to maturity
 
$
9,183
     
383
     
16
     
9,550
 

 
December 31, 2021
 
(dollars in thousands)
 
Amortized
Cost
   
Gross
Unrecognized
Gains
   
Gross
Unrecognized
Losses
   
Fair
Value
 
                         
Mortgage backed securities and collateralized mortgage obligations - residential
 
$
9,923
     
773
     
1
     
10,695
 
                                 
Total held to maturity
 
$
9,923
     
773
     
1
     
10,695
 

The following table distributes the debt securities included in the held to maturity portfolio as of March 31, 2022, based on the securities’ final maturity.  Actual maturities may differ because of securities prepayments and the right of certain issuers to call or prepay their obligations without penalty.

(dollars in thousands)
 
Amortized
Cost
   
Fair
Value
 
Mortgage backed securities and collateralized mortgage obligations - residential
 
$
9,183
     
9,550
 
   
$
9,183
     
9,550
 

All held to maturity securities are held at cost on the financial statements.  As of March 31, 2022 and December 31, 2021 held to maturity securities with a fair value of $2.6 million and $442 thousand had an unrecognized loss of less than 12 months of $16 thousand and one thousand, respectively.

There were no sales or transfers of held to maturity securities during the three months ended March 31, 2022 and 2021.

There were no allowance for credit losses recorded for held to maturity securities during the three months ended March 31, 2022. There were no securities on non-accrual status and all securities were performing in accordance with contractual terms.

Debt Securities
Management evaluates securities for other-than-temporary impairment (“OTTI”) at least on a quarterly basis, and more frequently when economic or market conditions warrant such an evaluation.  The investment securities portfolio is evaluated for OTTI by segregating the portfolio by type and applying the appropriate OTTI model.

In determining OTTI for debt securities, management considers many factors, including: (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, (3) whether the market decline was affected by macroeconomic conditions, and (4) whether the Company has the intent to sell the debt security or more likely than not will be required to sell the debt security before its anticipated recovery.  The assessment of whether any other‑than‑temporary decline exists involves a high degree of subjectivity and judgment and is based on the information available to management at a point in time.

When OTTI occurs, the amount of the OTTI recognized in earnings depends on whether management intends to sell the security or it is more likely than not it will be required to sell the security before recovery of its amortized cost basis.  If management intends to sell or it is more likely than not it will be required to sell the security before recovery of its amortized cost basis, the OTTI shall be recognized in earnings equal to the entire difference between the investment’s amortized cost basis and its fair value at the balance sheet date.  If management does not intend to sell the security and it is not more likely than not that the entity will be required to sell the security before recovery of its amortized cost basis, the OTTI on debt securities shall be separated into the amount representing the credit loss and the amount related to all other factors.  The amount of the total OTTI related to the credit loss is determined based on the present value of cash flows expected to be collected and is recognized in earnings through the provision for credit losses.  The amount of the total OTTI related to other factors is recognized in other comprehensive income, net of applicable taxes.

The Company does not intend to sell nor does it anticipate that it will be required to sell any of its securities in an unrealized loss position as of March 31, 2022. The Company’s ability and intent to hold these securities until recovery is supported by the Company’s strong capital and liquidity positions as well as it’s historically low turnover in the portfolio.

As of March 31, 2022, the Company’s securities portfolio included certain securities, which were in an unrealized loss position, and are discussed below.

U.S. government sponsored enterprises: In the case of unrealized losses on U.S. government sponsored enterprises, because the decline in fair value is attributable to changes in interest rates, and not credit quality, and because the Company does not have the intent to sell these securities and it is likely that it will not be required to sell the securities before their anticipated recovery, the Company does not consider these securities to be other-than-temporarily impaired at March 31, 2022.

Mortgage backed securities and collateralized mortgage obligations – residential:  At March 31, 2022, all mortgage backed securities and collateralized mortgage obligations held by the Company were issued by U.S. government sponsored entities and agencies, primarily Ginnie Mae, Fannie Mae and Freddie Mac, institutions which the government has affirmed its commitment to support.  Because the decline in fair value is attributable to changes in interest rates, and not credit quality, and because the Company does not have the intent to sell these securities and it is likely that it will not be required to sell the securities before their anticipated recovery, the Company does not consider these securities to be other‑than‑temporarily impaired at March 31, 2022.

Corporate Bonds & Other:  At March 31, 2022, corporate and other bonds held by the Company are investment grade quality.  Because the decline in fair value is attributable to changes in interest rates, and not credit quality, and because the Company does not have the intent to sell these securities and it is likely that it will not be required to sell the securities before their anticipated recovery, the Company does not consider these securities to be other-than-temporarily impaired at March 31, 2022.

Small Business Administration (SBA) - guaranteed participation securities:  At March 31, 2022, all of the SBA securities held by the Company were issued and guaranteed by U.S. Small Business Administration.  Because the decline in fair value is attributable to changes in interest rates, and not credit quality, and because the Company does not have the intent to sell these securities and it is likely that it will not be required to sell the securities before their anticipated recovery, the Company does not consider these securities to be other-than-temporarily impaired at March 31, 2022.